Neurological aspects of perinatal narcotic addiction and methadone treatment.
The semeiology and significance of neonatal "minor withdrawal" are developed. Its treatment and the consequent prevention of rebound, late, or classical withdrawal are proposed. Basic research implications are formulated.
D001307:Auditory Perception / Q000187:drug effects; D001341:Autonomic Nervous System / Q000187:drug effects*; D001724:Birth Weight; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D002657:Child Development / Q000187:drug effects; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D006556:Heroin Dependence / Q000150:complications* / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D008691:Methadone / Q000009:adverse effects*; D009043:Motor Activity / Q000187:drug effects; D009048:Motor Skills / Q000187:drug effects; D011187:Posture; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D012640:Seizures / Q000139:chemically induced; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D013391:Sucking Behavior / Q000187:drug effects; D014705:Verbal Behavior / Q000187:drug effects; D014796:Visual Perception / Q000187:drug effects
D008691:Methadone